Price:
Rs. 7,500.00
Sample Type: EDTA Whole Blood
Fasting Not Required
Notes: J8360
Frequently Asked Questions (FAQ's):
What does this test detect?
It identifies mutations in JAK2 exons 12 and 15 linked to myeloproliferative disorders.
Who should undergo this test?
Patients with elevated blood counts, unexplained thrombosis, or suspected myeloproliferative neoplasms.
Is fasting required?
No fasting is required.
What sample is needed?
An EDTA blood sample for molecular analysis.
How does Metropolis Healthcare perform this test?
Using PCR and advanced molecular techniques to detect JAK2 gene mutations accurately.
Can this test guide treatment decisions?
Yes, mutation status helps in diagnosis, prognosis, and therapy planning for myeloproliferative disorders.
Are additional tests recommended?
Metropolis Healthcare may suggest complete blood count, bone marrow studies, or other genetic tests for comprehensive assessment.
How long does it take to get results?
Results are typically available within 5–10 days depending on sample processing and analysis